Showing results (1631-1640 of 1,863) with videos related to

Sort By:
Pageof 187
Eclinicalmedicine|November 1, 2021
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trialGöran Tornling, Rohit Batta, Joanna C Porter, et al.
Frontiers in Endocrinology|June 25, 2019
Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical TrialShaminie J Athinarayanan, Rebecca N Adams, Sarah J Hallberg, et al.
Tissue Antigens|December 1, 2000
The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disordersA T Naluai, S Nilsson, L Samuelsson, et al.
The EMBO Journal|May 30, 2003
Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active siteMichael Arand, B Martin Hallberg, Jinyu Zou, et al.
Journal of Medicinal Chemistry|March 5, 2004
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivoYiqian Wan, Charlotta Wallinder, Berndt Johansson, et al.
Environmental Health Perspectives|August 19, 2008
Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic diseaseErik Melén, Fredrik Nyberg, Cecilia M Lindgren, et al.
Assay and Drug Development Technologies|April 15, 2016
Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule ScreeningKarin Engen, Ulrika Rosenström, Hanna Axelsson, et al.
Health and Quality of Life Outcomes|June 30, 2018
Inter-rater agreement of the Quality of Life-Alzheimer's Disease (QoL-AD) self-rating and proxy rating scale: secondary analysis of RightTimePlaceCare dataJosephine Römhild, Steffen Fleischer, Gabriele Meyer, et al.
Journal of Cell Science|May 5, 2018
Proteasome stress leads to APP axonal transport defects by promoting its amyloidogenic processing in lysosomesMaría Gabriela Otero, Ivan Fernandez Bessone, Alan Earle Hallberg, et al.
Biochemical and Biophysical Research Communications|May 28, 1993
A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60E Agsteribbe, A Huckriede, M Veenhuis, et al.
Pageof 187